StockData

Nika Pharmaceuticals, Inc (NIKA) shareholders

NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 0/30
$0.41+0.00 (0.00%)

Close on Oct 16, 2026Market cap $431.19MP/E –Yield –

Ownership

Who owns Nika Pharmaceuticals's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Dimitar Slavchev SavovCEO, CFO, President, Director, 10% owner455,589,50043.32%Mar 19, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Dimitar Slavchev Savov
CEO, CFO, President, Director, 10% owner
Mar 18, 2025Sale−2,000,000$0.25$500.00K455,589,500
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Jun 2, 2023Sale−3,500,000$0.02$70.00K–
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Jan 31, 2023Sale−1,500,000$0.01$15.00K–
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Jan 10, 2023Sale−6,300,000$0.01$63.00K–
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Oct 24, 2022Sale−3,000,000$0.04$120.00K–
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Sep 26, 2022Sale−1,250,000$0.02$25.00K–
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Sep 12, 2022Sale−7,000,000$0.02$140.00K–
Nika Pharmaceuticals, Inc
Secretary, Director, 10% owner
Jul 20, 2022Other+145,000,000–––
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Jul 20, 2022Other+333,181,000–––
Nika Pharmaceuticals, Inc
Secretary, Director, 10% owner
Apr 29, 2022Other+5,000,000$50000.00$250.00B5,000,000
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Apr 13, 2022Buy+11,489,000$0.01$114.89K–
Nika Pharmaceuticals, Inc
President, CEO, CFO, Director, 10% owner
Apr 13, 2022Other+10,000,000$3000000.00$30.00T10,000,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Nika Pharmaceuticals's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Dimitar Slavchev Savov
Officer, Director, 10% Stockholder
Apr 16, 202510,000,000$10.00MApr 16, 2025Stock Purchase Agreement

See a number that looks wrong?